HIM
Hotaling Investment Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $3.81M | Buy |
23,601
+75
| +0.3% | +$12.1K | 1.72% | 15 |
|
|
2022
Q3 | $3.16M | Buy |
23,526
+419
| +2% | +$56.2K | 1.51% | 18 |
|
|
2022
Q2 | $3.54M | Buy |
23,107
+1,087
| +5% | +$166K | 1.54% | 16 |
|
|
2022
Q1 | $3.57M | Buy |
22,020
+4,666
| +27% | +$756K | 1.37% | 15 |
|
|
2021
Q4 | $2.35M | Sell |
17,354
-26
| -0.1% | -$3.52K | 0.82% | 41 |
|
|
2021
Q3 | $1.88M | Buy |
17,380
+344
| +2% | +$37.1K | 0.78% | 44 |
|
|
2021
Q2 | $1.92M | Buy |
17,036
+13,067
| +329% | +$1.47M | 0.78% | 45 |
|
|
2021
Q1 | $429K | Sell |
3,969
-100
| -2% | -$10.8K | 0.19% | 85 |
|
|
2020
Q4 | $436K | Sell |
4,069
-25
| -0.6% | -$2.68K | 0.2% | 79 |
|
|
2020
Q3 | $359K | Sell |
4,094
-7,385
| -64% | -$648K | 0.19% | 83 |
|
|
2020
Q2 | $1.13M | Buy |
11,479
+7,310
| +175% | +$718K | 0.65% | 55 |
|
|
2020
Q1 | $318K | Sell |
4,169
-95
| -2% | -$7.25K | 0.24% | 79 |
|
|
2019
Q4 | $378K | Buy |
4,264
+405
| +10% | +$35.9K | 0.22% | 81 |
|
|
2019
Q3 | $292K | Sell |
3,859
-448
| -10% | -$33.9K | 0.19% | 87 |
|
|
2019
Q2 | $313K | Buy |
4,307
+5
| +0.1% | +$363 | 0.2% | 87 |
|
|
2019
Q1 | $347K | Sell |
4,302
-329
| -7% | -$26.5K | 0.23% | 85 |
|
|
2018
Q4 | $427K | Buy |
+4,631
| New | +$427K | 0.35% | 73 |
|